11 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Elucid PlaqueIQ

FDA 510(k)
FDA Class 2 ·Radiology

ELMED

FDA UDI
ELMED INCORPORATED·00842180159020·MULTI FLEX NEURO LASRGE INSTR. HOLDER 1" DIA, ...

MiniSPC Button

FDA UDI
APPLIED MEDICAL TECHNOLOGY, INC.·00842071152680·24F x 1.5cm MiniSPC Low Profile Suprapubic Cath...

NEURO-AUDIO

FDA 510(k)
FDA Class 2 ·Ear, Nose, Throat

GE DATEX-OHMEDA HELIOX DELIVERY SYSTEM

FDA 510(k)
FDA Class 2 ·Anesthesiology

1ML BD¿ TUBERCULIN SYRINGE, 27GX1/2" BD PRECISIONGLIDE¿ DETACHABLE NEEDLE

FDA Adverse Event
Malfunction ·BECTON DICKINSON MEDICAL SYSTEMS·Product code FMF·March 20, 2017

1 ML BD¿ TB SYRINGE WITH 27G X 1/2IN. BD PRECISIONGLIDE¿ DETACHABLE NEEDLE

FDA Adverse Event
Injury ·BECTON DICKINSON MEDICAL SYSTEMS·Product code FMF·December 20, 2016

NOVASURE IMPEDANCE CONTROLLED EA SYSTEM

FDA Adverse Event
Injury ·CYTYC SURGICAL PRODUCTS·Product code MNB·November 21, 2008

LIFEVEST WCD 400 SYSTEM

FDA Adverse Event
Malfunction ·ZOLL LIFECOR CORPORATION·Product code MVK·August 10, 2011

ROTABLATOR ROTATIONAL ATHERECTOMY SYSTEM

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC - COSTA RICA (HEREDIA)·Product code MCX·July 22, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014